Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer

24 Sept 2020

Abstract excerpt

An increasing number of studies have indicated that red blood cell distribution width (RDW) may be a novel biomarker for the diagnosis and prognosis of various malignancies. However, to date, data on the association of RDW with non-small cell lung cancer (NSCLC) are unclear. Our present study aimed to explore the value of RDW in NSCLC patients. A total of 338 NSCLC patients, 109 small cell lung cancer (SCLC)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Biomarkers in Disease Prognosis
Share to MRI in cancer diagnosis
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32973271
DOI: 10.1038/s41598-020-72585-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancerPMID 32973271Read ↗

Application of Circulating Genetically Abnormal Cells in the Early-stage Diagnosis of Lung CancerSemantic proximity Read ↗

Association of red cell distribution width to albumin ratio with risk of all-cause and cause-specific mortality: two prospective cohort studiesSemantic proximity Read ↗

Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.Semantic proximity Read ↗

Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer managementSemantic proximity Read ↗

Expression and Diagnostic Efficacy of miR-126-5p and miR-34c-3p in Serum Extracellular Vesicles of Non-Small Cell Lung Cancer PatientsSemantic proximity Read ↗

Serum albumin as a prognostic predictor reflecting host immunity in patients with non–small cell lung cancerSemantic proximity Read ↗

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study.Semantic proximity Read ↗

Blood-Based Gene Expression Signatures in Non–Small Cell Lung CancerSemantic proximity Read ↗

Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy.Semantic proximity Read ↗

Combination of Circulating Cell-Free DNA and Metabolic Tumor Burden to Distinguish Non-Small Cell Lung Cancer from TuberculosisSemantic proximity Read ↗

Impact of Jaundice-Induced Elevated Red Blood Cell Distribution Width on Survival Outcomes in Pancreatic Cancer Patients: A Retrospective Cohort StudySemantic proximity Read ↗

Platelet/lymphocyte ratio is a significant prognostic factor for targeted therapy in patients with EGFR-mutated non-small-cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.